Set Your Sights On Acumen Pharmaceuticals Inc (NASDAQ: ABOS)’S Upside Potential
Acumen Pharmaceuticals Inc (ABOS) concluded trading on Thursday at a closing price of $0.90, with 0.49 million shares of worth about $0.44 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -61.34% during that period and on April 17, 2025 the price saw a […]
Acumen Pharmaceuticals Inc (NASDAQ: ABOS): The Best-Of-Breed For Investing?
RA Capital Management LP recently announced the acquisition of new stake in Acumen Pharmaceuticals Inc (NASDAQ:ABOS). The institutional investor has increased its shareholding in the Healthcare company by 52.82% to 14.93 million shares with purchase of 5.16 million shares. This fresh investment now brings its stake to 25.79% valued currently at $35.84 million. In addition, […]
